Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_409f06b5c0f18b29f161f1be3b4525b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7a7c9e2fe2dd5a7902b96f7860d10dc0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89edd8286d47c7c0b7ccd8d335d5a85d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3899a93c972ce60b070fca823112248 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 |
filingDate |
2001-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a435562458598ea89578064a5d00514 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_176b7e1e96b586cd0d90786c1fe644eb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e4933d2aada6f84318e3b58e8bb75ba |
publicationDate |
2001-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-0164223-A1 |
titleOfInvention |
Method for treating or preventing depression |
abstract |
A neurokinin-1 antagonist or an alpha-2 adrenoreceptor agonist provide an effective therapy in conjunction with a PDE4 inhibitor for the treatment or prevention of depression and/or anxiety. These combinations minimize the side effects of nausea and/or emesis associated with the PDE4 inhibitor and may also provide beneficial antidepressant and/or anti-anxiety effects. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10696647-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2875810-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03105902-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015075155-A1 |
priorityDate |
2000-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |